Showing 653 results

Filters Content type: News, Editors' picks Topic: New & experimental hepatitis C treatment

News and information about clinical trials and regulatory approval of new medications to treat hepatitis C.

New & experimental hepatitis C treatment

First Sustained Response Data for Polymerase Inhibitor Mericitabine

Editor's pick
HIVandhepatitis.com
5 April 2011
New & experimental hepatitis C treatment

Avalanche of hepatitis C products on the way

Editor's pick
Pharma Times
4 April 2011
New & experimental hepatitis C treatment

Bristol-Myers Interferon-Free Combo Cured Hepatitis Patients

Editor's pick
Bloomberg
4 April 2011
New & experimental hepatitis C treatment

Merck, J&J’s New Hepatitis C Treatments Fetch $31,000 in France

Editor's pick
Bloomberg
4 April 2011
New & experimental hepatitis C treatment

Idera Pharmaceuticals Presents Data from a Phase 1 Clinical Trial of IMO-2125 in Treatment-Naïve Genotype 1 HCV Patients at EASL 2011

Editor's pick
Business Wire
4 April 2011
New & experimental hepatitis C treatment

Quadruple therapy shows 100 percent SVR for HCV patients previously unresponsive to treatment

Editor's pick
Eurekalert HIV
2 April 2011
Hepatitis C transmission & prevention

First vaccine for viral hepatitis C could become a reality

Editor's pick
Eurekalert Inf Dis
1 April 2011
New & experimental hepatitis C treatment

Inhibitex Reports Positive Safety and Antiviral Data from Its Phase 1b Study of HCV Nucleotide Inhibitor INX-189

Editor's pick
Pipeline Review
1 April 2011
New & experimental hepatitis C treatment

'Fantastic' data on Novartis' first-in-class hep C antiviral

Editor's pick
Pharma Times
1 April 2011
New & experimental hepatitis C treatment

Well-known statin could be recycled as HCV therapy supplement

Editor's pick
EASL
1 April 2011
Hepatitis C treatment

We’re getting there: towards a comprehensive hepatitis C cure

News
1 April 2011
New & experimental hepatitis C treatment

Results From Phase 3 REALIZE Study Showed Telaprevir-Based Therapy Significantly Improved SVR (Viral Cure) Rates in People Whose Prior Treatment For Hepatitis C Was Unsuccessful

Editor's pick
Business Wire
31 March 2011
New & experimental hepatitis C treatment

Interim Phase 2 Data Showed Rapid Viral Response to VX-222 in Combination with Telaprevir, Pegylated-Interferon and Ribavirin Among People With Hepatitis C

Editor's pick
Business Wire
31 March 2011
New & experimental hepatitis C treatment

Telaprevir Improves Viral Cure Rates After Previous Treatment Failure

Editor's pick
Poz magazine news
31 March 2011
New & experimental hepatitis C treatment

Pharmasset Initiates Phase 2b ATOMIC Trial of PSI-7977 for Multiple HCV Genotypes

Editor's pick
PR Newswire
30 March 2011
New & experimental hepatitis C treatment

Achillion ACH-1625 hepatitis drug shows promise in mid-stage trial

Editor's pick
Reuters
30 March 2011
New & experimental hepatitis C treatment

Next Stage for Biotron's Hep C Drug

Editor's pick
Hepatitis Central
23 March 2011
New & experimental hepatitis C treatment

Telaprevir, Boceprevir for Hep C Approaching FDA Finish Line

Editor's pick
Poz
16 March 2011
New & experimental hepatitis C treatment

Copy of Telaprevir, Boceprevir for Hep C Approaching FDA Finish Line

Editor's pick
Poz
16 March 2011
New & experimental hepatitis C treatment

Who will win the hepatitis C market?

Editor's pick
Seeking Alpha
15 March 2011
New & experimental hepatitis C treatment

The Hepatitis C Pipeline Report

Editor's pick
Treatment Action Group
9 March 2011
New & experimental hepatitis C treatment

Telaprevir works well for people with HIV/HCV co-infection

News
2 March 2011
Hepatitis C treatment

Copy of Hep C Treatment Telaprevir Gets Fast-Tracked FDA Review

Editor's pick
Kaiser Daily Global Health Policy Report
21 January 2011
Hepatitis C treatment

Hep C Treatment Telaprevir Gets Fast-Tracked FDA Review

Editor's pick
AIDSMeds
21 January 2011